Drug Profile
LC 231306
Alternative Names: LC23-1306Latest Information Update: 17 Aug 2017
Price :
$50
*
At a glance
- Originator LG Life Sciences
- Class Antiplatelets; Antithrombotics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Acute coronary syndromes
Most Recent Events
- 09 Apr 2012 Phase-I clinical trials in Acute coronary syndromes in South Korea (unspecified route)
- 23 Feb 2012 Preclinical trials in Acute coronary syndromes in South Korea (unspecified route)